Our Director of Ex Vivo Models Dr. Ben Hopkins is using organoids to bridge the gap between lab research and clinical care! "Our platform is increasingly focused on identifying therapies for patients who are in need of better options." Learn more: eipm.weill.cornell.edu/news/bridgin...

Great new paper in Blood Advances, "MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell Lymphoma," by our EIPM Directior Olivier Elemento, PhD and colleagues. Learn more: ashpublications.org/bloodadvance...

Please join us in congratulating Dr. Andrea Sboner from the Pathology and Laboratory Medicine department and the EIPM on completing yesterday's Philadelphia Marathon--in his lucky NewYork-Presbyterian t-shirt!

"Longitudinal genomic analysis of five cases of recurrent thymomas," was published in The Journal of Thoracic Oncology on November 18th by a range of EIPM colleagues! www.jto.org/article/S155...

Don't miss the upcoming presentation, "Applying Precision Oncology to Identify Tumor Specific Vulnerabilities in Ovarian Cancer," by our Director of Ex Vivo Models Dr. Benjamin Hopkins (@Degreesofhealth) this Friday at noon in Belfer BB 204-B!

"Clinical AI’s challenge isn’t just getting deployed – it’s being used. The Epic Sepsis Model runs in hundreds of hospitals, but external validation found it missing 67% of sepsis cases while generating false alerts on 18% of patients. This pattern isn’t unique: oncodaily.com/voices/ai-mo...

Please join us December 16th!

We hope you can join us this Friday at 11 am!

Our colleague Dr. Ben Hopkins (right) leading a tour of our labs and briefing representatives from the offices of U.S. Senators, U.S. House of Representatives, N.Y. State Senator, N.Y. State Assemblymember, and NYC Council. We enjoy explaining the research we do and why it's vitally important!

Congratulations Dr. Elemento! www.webofscience.com/wos/author/r...

"It is such a privilege to be part of a team and hospital that can provide this kind of exceptional care to our patients for even rare conditions (like Chiari malformation) that aren't well studied or understood,” said EIPM Member Dr. Jeffrey Greenfield. Learn more: people.com/chiari-malfo...

We encourage WCM clinicians, researchers & trainees to sign-up today for our bi-weekly one-hour #AI Clinic sessions to help you master advanced #AI tools like @claudeai @ChatGPTapp @XBench_Gemini and more! www.cognitoforms.com/IPM3/AIClini...

Dr. Juan Miguel Mosquera and colleagues from the Pathology and Laboratory Medicine department and the Englander Institute for Precision Medicine at Weill Cornell Medicine are proud to share the acceptance of eleven (11!) abstracts at @USCAP2026! Collaborations with Isabl and BostonGene!

We hope you can join us today at noon!

Don't miss the new Future Oncology podcast episode, "Treatment options in hormone-sensitive prostate cancer: targeting the androgen-sensitive pathway," featuring our Clinical Director Dr. Cora N. Sternberg as special guest! www.tandfonline.com/doi/full/10....

Don't miss our EIPM colleague Dr. Scott T. Tagawa's interview with @GUOncologyNow, "LuPSMA Plus ADT: Setting the Stage for Longer Benefits in mHSPC," on new metastatic hormone-sensitive prostate cancer research presented at #ESMO25. www.guoncologynow.com/post/lupsma-...

Our EIPM colleague Dr. Lisa Newman was the beneficiary of a #ShoesForACure fundraiser featured in a recent Women's Wear Daily news article timed to #BreastCancerAwarenessMonth! wwd.com/footwear-new...

Congrats to our colleague Dr. Vivek Mittal on his new paper, "Epigenetic regulation of chromosomal instability by EZH2 methyltransferase," in Cancer Discovery with EIPM Director Olivier Elemento, PhD, and Dr. Liron Yoffe, and Bhavneet Bhinder and Marvel Tranquille! aacrjournals.org/cancerdiscov...

“Breast cancer disparities research is essential in achieving health equity, and in identifying the root causes and optimized treatment for this disease," said Dr. Lisa Newman (@LANewmanMD) from WCM's Dept. of Surgery and the EIPM. #BreastCancerAwarenessMonth swimsuit.si.com/swimnews/thi...

Congratulations to our Clinical Director Dr. Cora Sternberg for her work on "Safety and Performance of a Multi-Cancer Early Detection (#MCED) Test in an Intended Use Population: Initial Results from the #PATHFINDER 2 Study," presented at #esmo2025 Saturday!

Don't miss our next EIPM Journal Club, "Bridging Gaps with #GenerativeAI: Enhancing #Hypertension Monitoring Through Patient and Provider Insights," presented by Katerina Andreadis from @nyugrossman 's Vilcek Institute of Graduate Biomedical Sciences this Thursday!

We hope you joined us for today's "Integrated Histopathologic Modeling of Detailed Tumor Subtypes and Actionable Biomarkers," an EIPM Precision Medicine AI Working Group presentation by Dr. Kevin Boehm from Memorial Sloan Kettering CancerCenter! It was terrific, thanks @kevinmboehm!

Congratulations to our former colleague Tomer Yaron-Barir who worked with our Director Olivier Elemento on being selected a '25 STAT Wunderkind! www.statnews.com/wunderkinds/...

“Our technology allows clinical labs to use a small biopsy taken in a doctor’s office and ultimately produce a trillion or more functional endothelial cells,” said EIPM's Dr. Shahin Rafii about his new research published in Nature Cardiovascular Research. eipm.weill.cornell.edu/news/galvani...

Please join us!

Check out the latest UroToday Beyond the Abstract paper, "Evaluating Surrogates for Overall Survival in the Adjuvant Treatment of #BladderCancer with #Chemotherapy," by our Clinical Director Dr. Cora N. Sternberg! #precisionmedicine www.urotoday.com/recent-abstr...

We hope you can join us on October 30th!

Please join us in congratulating our Clinical Director Dr. Cora N. Sternberg on being named to Research.com's 2025 list of the Top 1000 Female Scientists! She's ranked #305 in the U.S., and #516 in the world! research.com/careers/worl...

“Our study [in Cancer Discovery] suggests a new therapeutic approach to block metastasis before it starts, and help patients overcome triple negative breast cancer,” said Dr. Vivek Mittal (@MittalLab) from the Meyer Cancer Center and there EIPM. news.weill.cornell.edu/news/2025/10...

We hope you can join us two weeks from today!

We hope you enjoy this new article from The Scientist "How Circulating Tumor Cells Can Help Diagnose Cancer Early," with our colleague Dr. Carolina Reduzzi. www.the-scientist.com/how-circulat...

Should people with triple-negative #breastcancer be offered hormonal therapy to reduce the risk of recurrence? Learn what EIPM Member Dr. Lisa Newman has discovered via her new @BreastCancer podcast: www.breastcancer.org/podcast/tnbc...

This Thursday at 1 pm our Director of Ex Vivo Models, Dr. Ben Hopkins (@Degreesofhealth), will present "Placing #Purines in #PrecisionMedicine, From N=1 to a Metabolic Reliance in #KRAS-Mutant Tumors" in Belfer #1401 and via Zoom (DM for info).

Thanks to our Elemento Lab colleague Valerie Gallegos for presenting an engaging Precision Medicine Journal Club talk yesterday about the Science Direct paper, "Cancer-associated Fibroblast-derived Fibulin-5 Promotes Radioresistance in Non-Small-Cell Lung Cancer."

Rescheduled to today at 3 pm, we hope you can join us in person or via Zoom!

A new study in Cell Reports by EIPM researchers discovered that adversity in the womb configured a small percentage of brain cells to be overly active when faced with a threatening situation, creating a vulnerability to anxiety. Learn more: news.weill.cornell.edu/news/2025/09...

Please join us in congratulating internationally recognized medical oncologist Dr. Allyson J. Ocean on being named Director of the Early Onset Gastrointestinal Cancer Program at the Englander Institute for Precision Medicine effective August 1st!

Congratulations to our EIPM colleague Dr. Joseph Scarpa from @WCMAnesthesia on his new NIA/AFAR grant to study “The Impact of Biological Age on Surgical Outcomes," with EIPM's Dr. Jan Krumsiek! Learn more: anesthesiology.weill.cornell.edu/news/dr-jose...

"For artificial intelligence to truly transform patient care, it must first be held to the same standard of evidence as the medicines it promises to enhance," a STAT News opinion by EIPM Director Olivier Elemento, Clinical Dir. Cora N. Sternberg and Dr. Sean Khozin. www.statnews.com/2025/08/28/m...

“We are making advancements in pancreatic cancer over the last five to ten years; however, the advancements have come out slowly,” Dr. Allyson Ocean, a member of the EIPM. Learn more: www.survivornet.com/articles/bac...

We hope you can join us!

Great new paper in Urologic Oncology: Seminars and Original Investigations by our Clinical Director Dr. Cora N. Sternberg: "Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy." Check it out: www.sciencedirect.com/.../pii/S107...

"Redefining druggable targets with artificial intelligence. We highlight the failure of current target taxonomies and the need for benchmarking datasets, and re-evaluate clinical validation for novel AI-driven modalities." Nature Biotechnology commentary. www.nature.com/articles/s41...

Terrific student presentations yesterday by the 2025 MCC+EIPM Summer Internship Program participants! We thank all of the participating students, as well as our mentors and staff who contributed so generously of their time to make this another wonderful summer program!

We hope you can join us!

Congratulations to Dr. Andrea Sboner from the EIPM and the Pathology and Laboratory Medicine department on his new guest editorial in The Journal of Molecular Diagnostics, "Informatics Powering Data to Shape the Future of Molecular Pathology." www.jmdjournal.org/article/S152...

So great to host Daniela Sia, Ph.D., from the Icahn School of Medicine at Mount Sinai, today for her talk, "Discovery of Novel Therapeutic Vulnerabilities in Cholangiocarcinoma," shown here with our EIPM colleagues, Drs. Benjamin Hopkins (left) and Andrea Sboner!

Don't miss the latest OncoDaily blog post by EIPM Director Olivier Elemento, PhD, "AI-Designed Genome Editors Are Here," on a stunning new paper in Nature that used a generative AI approach to design a novel protein from the ground up! oncodaily.com/science/ai-d...

Great new paper identified that signaling through the immune checkpoint programmed death receptor 1 strongly impacts the early specification of CD8+ TRM cells in the skin, by our EIPM Drs. Niroshana Anandasabapathy, Akanksha Verma, and Director Olivier Elemento! www.nature.com/articles/s41...